LHC Group, Inc. (NASDAQ:LHCG) Expected to Announce Earnings of $1.26 Per Share

Wall Street analysts forecast that LHC Group, Inc. (NASDAQ:LHCG) will post earnings of $1.26 per share for the current quarter, according to Zacks Investment Research. Five analysts have provided estimates for LHC Group’s earnings. The lowest EPS estimate is $1.22 and the highest is $1.29. LHC Group posted earnings of $0.75 per share during the same quarter last year, which would suggest a positive year-over-year growth rate of 68%. The business is expected to issue its next quarterly earnings report after the market closes on Wednesday, May 5th.

According to Zacks, analysts expect that LHC Group will report full-year earnings of $5.88 per share for the current year, with EPS estimates ranging from $5.76 to $6.24. For the next financial year, analysts expect that the business will report earnings of $6.67 per share, with EPS estimates ranging from $6.40 to $7.07. Zacks Investment Research’s earnings per share averages are an average based on a survey of research firms that cover LHC Group.

LHC Group (NASDAQ:LHCG) last issued its earnings results on Thursday, February 25th. The health services provider reported $1.40 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.37 by $0.03. LHC Group had a net margin of 5.00% and a return on equity of 9.71%. The company had revenue of $532.33 million for the quarter, compared to analysts’ expectations of $533.67 million.

Several research analysts have recently weighed in on the stock. Truist lifted their price target on shares of LHC Group from $245.00 to $260.00 in a research note on Tuesday, January 5th. Deutsche Bank Aktiengesellschaft lifted their price target on shares of LHC Group from $240.00 to $260.00 and gave the stock a “buy” rating in a research note on Monday, February 8th. They noted that the move was a valuation call. Credit Suisse Group assumed coverage on shares of LHC Group in a research note on Monday, January 25th. They set an “outperform” rating and a $255.00 target price on the stock. Finally, Zacks Investment Research cut shares of LHC Group from a “hold” rating to a “sell” rating and set a $192.00 target price on the stock. in a research note on Wednesday, March 3rd. One research analyst has rated the stock with a sell rating, one has given a hold rating and six have given a buy rating to the company. LHC Group presently has an average rating of “Buy” and a consensus target price of $229.11.

Several institutional investors have recently bought and sold shares of the company. Great Diamond Partners LLC increased its holdings in shares of LHC Group by 6.0% in the 4th quarter. Great Diamond Partners LLC now owns 1,025 shares of the health services provider’s stock worth $218,000 after buying an additional 58 shares during the last quarter. FDx Advisors Inc. boosted its stake in shares of LHC Group by 5.9% during the 4th quarter. FDx Advisors Inc. now owns 1,049 shares of the health services provider’s stock worth $224,000 after purchasing an additional 58 shares during the period. Crossmark Global Holdings Inc. boosted its stake in shares of LHC Group by 1.6% during the 4th quarter. Crossmark Global Holdings Inc. now owns 3,845 shares of the health services provider’s stock worth $820,000 after purchasing an additional 60 shares during the period. Parallel Advisors LLC boosted its stake in shares of LHC Group by 100.0% during the 4th quarter. Parallel Advisors LLC now owns 124 shares of the health services provider’s stock worth $26,000 after purchasing an additional 62 shares during the period. Finally, Sheets Smith Wealth Management boosted its stake in shares of LHC Group by 2.2% during the 4th quarter. Sheets Smith Wealth Management now owns 3,340 shares of the health services provider’s stock worth $712,000 after purchasing an additional 71 shares during the period. Hedge funds and other institutional investors own 91.82% of the company’s stock.

Shares of LHC Group stock opened at $207.04 on Friday. The company’s fifty day simple moving average is $200.58 and its 200-day simple moving average is $205.72. The stock has a market capitalization of $6.56 billion, a PE ratio of 62.93, a P/E/G ratio of 2.53 and a beta of 0.46. LHC Group has a 1-year low of $116.26 and a 1-year high of $236.81. The company has a debt-to-equity ratio of 0.01, a current ratio of 0.99 and a quick ratio of 0.99.

LHC Group Company Profile

LHC Group, Inc, a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. The company's Home Health Services segment offers home nursing services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education; medically-oriented social services; and physical, occupational, and speech therapy services.

Featured Article: What is Cost of Goods Sold (COGS)?

Get a free copy of the Zacks research report on LHC Group (LHCG)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.